Mittal Seema, Sharma Madhu, Chaudhary Uma
Department of Microbiology, Pt. B.D.S. PGIMS, Rohtak-124001, Haryana, India.
Infect Disord Drug Targets. 2015;15(3):196-201. doi: 10.2174/1871526515666150916141907.
Escherchia coli isolated, from urine samples were studied for their antibiotic susceptibility patterns, with special reference to the new antimicrobial compound fosfomycin and their correlation with various virulence factors.
The mid stream urine samples received in the department were processed and identification was done by using the standard culture and identification techniques. The antibiotic susceptibility testing was done by modified Kirby-Bauer disk diffusion and the disk diffusion method was used to confirm the ESBL, AmpC, MBL production by the UPEC. Various virulence factors like hemolysin, haemagglutinaton, gelatinase, siderophore production, biofilm formation, serum resistance and hydrophobicity were detected.
Fosfomycin was found to be most effective agent (100%) against uropathogenic E.coli followed by netilmicin (89.5%). The least effective agents were ampiciilin and cotrimoxazole. Twenty nine percent (29%) isolates were found to be multi drug resistant (MDR).
The testing of the newer therapeutic agents like fosfomycin will add on to therapeutics for UTI's.
对从尿液样本中分离出的大肠杆菌进行研究,以了解其抗生素敏感性模式,特别关注新型抗菌化合物磷霉素及其与各种毒力因子的相关性。
对科室接收的中段尿样本进行处理,并采用标准培养和鉴定技术进行鉴定。通过改良的 Kirby-Bauer 纸片扩散法进行抗生素敏感性测试,并使用纸片扩散法确认由尿道致病性大肠杆菌产生的超广谱β-内酰胺酶(ESBL)、AmpC 酶、金属β-内酰胺酶(MBL)。检测了各种毒力因子,如溶血素、血凝素、明胶酶、铁载体产生、生物膜形成、血清抗性和疏水性。
发现磷霉素是针对尿道致病性大肠杆菌最有效的药物(100%),其次是奈替米星(89.5%)。最无效的药物是氨苄西林和复方新诺明。发现 29%的分离株具有多重耐药性(MDR)。
对磷霉素等新型治疗药物的测试将为尿路感染的治疗增添新方法。